{
  "table_name": "ADDL_PATH_FINDINGS",
  "description": "Stores data for College of American Pathologists (CAP) form field Additional Pathologic Findings.",
  "primary_key": {
    "column_name": "RESULT_ID",
    "ordinal_position": "1"
  },
  "columns": [
    {
      "index": 2,
      "name": "RESULT_ID",
      "type": "VARCHAR",
      "discontinued": false,
      "description": "The unique identifier for the result record."
    },
    {
      "index": 7,
      "name": "LINE",
      "type": "INTEGER",
      "discontinued": false,
      "description": "The line number for the information associated with this record. Multiple pieces of information can be associated with this record."
    },
    {
      "index": 12,
      "name": "ADDL_PATH_FNDNGS_C_NAME",
      "type": "VARCHAR",
      "discontinued": false,
      "description": "CAP synoptic form item: Additional Pathologic Findings.\n\n\nMay contain organization-specific values: Yes\n\n\n Category Entries: \n\n\nNone identified\n\n\nTumor necrosis\n\n\nDegenerative changes\n\n\nDysplasia / adenoma\n\n\nCrohn�s disease\n\n\nCondyloma accuminatum\n\n\nDysplasia\n\n\nAssociated rectal carcinoma (Paget disease)\n\n\nAppendicitis\n\n\nPerforation, not at tumor\n\n\nChronic ulcerative colitis\n\n\nDiverticulosis\n\n\nLow-grade neuroendocrine tumor (carcinoid tumor)\n\n\nCholedochal cyst\n\n\nPrimary sclerosing cholangitis\n\n\nStones\n\n\nCirrhosis / severe fibrosis (Ishak fibrosis score 5-6)\n\n\nBiliary stones\n\n\nChronic hepatitis\n\n\nInflammatory bowel disease\n\n\nAdenoma(s)\n\n\nChronic ulcerative proctocolitis\n\n\nDysplasia arising in inflammatory bowel disease\n\n\nOther polyps\n\n\nHyperplasia\n\n\nAtypical hyperplasia\n\n\nEndometrial intraepithelial neoplasia (EIN)\n\n\nIntestinal metaplasia (Barrett's esophagus)\n\n\nEsophagitis\n\n\nGastritis \n\n\nSalpingitis\n\n\nCholelithiasis\n\n\nChronic cholecystitis\n\n\nAcute cholecystitis\n\n\nDiffuse calcification (porcelain gallbladder)\n\n\nInflammation\n\n\nCirrhosis / fibrosis\n\n\nIron overload\n\n\nHepatitis \n\n\nHepatocellular dysplasia\n\n\nSteatosis\n\n\nInsufficient tissue, partial nephrectomy specimen <5mm adjacent non-neoplastic kidney\n\n\nGlomerular disease\n\n\nTubulointerstitial disease\n\n\nVascular disease\n\n\nKeratinizing dysplasia\n\n\nNon-keratinizing dysplasia\n\n\nSquamous metaplasia\n\n\nEpithelial hyperplasia\n\n\nColonization\n\n\nAtypical adenomatous hyperplasia\n\n\nSquamous dysplasia\n\n\nMetaplasia\n\n\nDiffuse neuroendocrine hyperplasia\n\n\nEmphysema\n\n\nSialadenitis\n\n\nTumor associated lymphoid proliferation\n\n\nAsbestos bodies\n\n\nPleural plaque\n\n\nPulmonary interstitial fibrosis\n\n\nNevus remnant\n\n\nCarcinoma in situ (Note M)\n\n\nEpithelial dysplasia (Note M)\n\n\nEndometriosis\n\n\nEndosalpingiosis\n\n\nChronic pancreatitis\n\n\nAcute pancreatitis\n\n\nAdenomatosis (multiple endocrine tumors, each less than 5 mm in greatest dimension)\n\n\nPancreatic intraepithelial neoplasia\n\n\nFerruginous bodies\n\n\nMesothelial inclusion cysts\n\n\nHigh-grade prostatic intraepithelial neoplasia (PIN) (Note F)\n\n\nNodular prostatic hyperplasia\n\n\nUrothelial carcinoma in situ\n\n\nUrothelial dysplasia (low-grade intraurothelial neoplasia)\n\n\nInflammation / regenerative changes\n\n\nTherapy-related changes\n\n\nPyelitis cystica and / or glandularis\n\n\nKeratinizing squamous metaplasia\n\n\nIntestinal metaplasia\n\n\nLithiasis\n\n\nCalcifications\n\n\nMitotic Rate: Number of mitoses per 40x objective with a field area of 0.152 mm2 \n\n\nApoptosis\n\n\nBasophilic vascular deposits\n\n\nInflammatory cells\n\n\nHemorrhage\n\n\nNeovascularization\n\n\nCeliac disease\n\n\nPolyp(s)\n\n\nIntratubular germ cell neoplasia\n\n\nHemosiderin-laden macrophages\n\n\nAtrophy\n\n\nAge-appropriate involution changes\n\n\nFibrosis\n\n\nCortical hyperplasia\n\n\nCystic changes in tumor\n\n\nCystic changes in adjacent thymus\n\n\nAdenomatoid nodule(s) or Nodular follicular disease (e.g., nodular hyperplasia, goitr\n\n\nDiffuse hyperplasia (Graves� disease)\n\n\nThyroiditis\n\n\nParathyroid gland(s)\n\n\nC-cell hyperplasia\n\n\nImplantation site\n\n\nCautery artifact\n\n\nUreteritis or pyelitis cystica and / or glandularis\n\n\nCystitis cystica glandularis\n\n\nKoilocytosis\n\n\nIntraepithelial neoplasia\n\n\nMicrovascular patterns\n\n\nVascular invasion (tumor vessels or other vessels)\n\n\nDegree of pigmentation\n\n\nInflammatory cells / tumor infiltrating lymphocytes\n\n\nDrusen\n\n\nRetinal detachment\n\n\nInvasion of Bruch�s membrane\n\n\nNevus\n\n\nAdenoarcinoma in-situ\n\n\nCarcinoma in-situ\n\n\nAtypical Adenosis\n\n\nVulvar intraepithelial neoplasia (VIN) 3 (severe dysplasia / carcinoma in situ)\n\n\nOther"
    }
  ]
}
